Keywords: AstraZeneca, Novartis, Russia, Research center, Production facility

AstraZeneca plans R&D center in Russia and Novartis breaks ground on new facility

Article | 17 June 2011

Print This

In yet more illustrations of multinational drug majors getting a foot hold in the fast-growing BRIC (Brazil, Russia, India and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in